A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 38/10 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61P 25/28 (2006.01) C07K 5/00 (2006.01) C12N 15/85 (2006.01) C12N 15/86 (2006.01)
Patent
CA 2513722
The invention provides methods useful for effecting prophylaxis or treatment of Alzheimer's disease. Such methods entail administering A-beta fragments from a central or C-terminal regions of A-beta. Such fragments can induce a polyclonal mixture of antibodies that specifically bind to soluble A-beta without binding to plaques. The antibodies can inhibit formation of amyloid deposits of A-beta in the brain of a patient from soluble A.beta. thus preventing or treating the disease. Fragment A-beta 15-24 and subfragments of 5-10 contiguous amino acids thereof are preferred immunogens due to their capacity to generate a high titer of antibodies.
L'invention concerne des méthodes utiles de prophylaxie ou de traitement de la maladie d'Alzheimer. De telles méthodes consistent à administrer des fragments de A-beta issus de régions centrales ou C-terminales de A-beta. De tels fragments peuvent induire un mélange polyclonal d'anticorps se liant de manière spécifique à A-beta soluble sans se lier à des plaques. Les anticorps peuvent inhiber la formation de dépôts amyloïdes de A-beta dans le cerveau d'un patient à partir de A.beta. soluble, prévenant ou traitant ainsi la maladie. Un fragment A-beta 15-24 et des sous-fragments comprenant entre 5 et 10 acides aminés contigus sont, par conséquent, des immunogènes préférés, en raison de la capacité de ceux-ci de produire un titre élevé d'anticorps.?¿
Bard Frederique
Seubert Peter A.
Vasquez Nicki
Yednock Ted
Gowling Lafleur Henderson Llp
Janssen Alzheimer Immunotherapy
Neuralab Limited
Wyeth
Wyeth Llc
LandOfFree
Active immunization to generate antibodies to soluble a-beta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Active immunization to generate antibodies to soluble a-beta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active immunization to generate antibodies to soluble a-beta will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1547566